Artisan Partners’s Sarepta Therapeutics SRPT Stock Holding History

Artisan Partners’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-439,807	Closed	-$53.3M	–	355
2023 Q3	$53.3M	Sell	439,807 -1,064	-0.2%	-$120K	0.09%	192
2023 Q2	$50.5M	Buy	440,871 +2,705	+0.6%	+$349K	0.08%	210
2023 Q1	$60.4M	Buy	+438,166	New	+$56.8M	0.1%	195
2021 Q1	–	Sell	-531,012	Closed	-$90.5M	–	384
2020 Q4	$90.5M	Sell	531,012 -22,097	-4%	-$3.27M	0.11%	182
2020 Q3	$77.7M	Buy	553,109 +6,352	+1%	+$965K	0.11%	174
2020 Q2	$87.7M	Buy	546,757 +43,026	+9%	+$5.86M	0.14%	151
2020 Q1	$49.3M	Sell	503,731 -16,164	-3%	-$1.85M	0.11%	178
2019 Q4	$67.1M	Sell	519,895 -120,744	-19%	-$12.2M	0.12%	163
2019 Q3	$48.3M	Buy	+640,639	New	+$75.7M	0.09%	183

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Artisan Partners's SRPT Position: Q4 2023 in Review

Artisan Partners sold out of Sarepta Therapeutics (SRPT) in Q4 2023, closing a stake of 439,807 shares — an estimated $53.3M sold.

Artisan Partners first reported a position in SRPT in Q3 2019 and held it in 9 quarters. The position peaked at $90.5M in Q4 2020. 395 funds tracked by Wall St. Rank hold SRPT as of Q4 2023.

Artisan Partners reported no remaining Sarepta Therapeutics position as of Q4 2023 after selling out during the quarter.
Artisan Partners sold 439,807 Sarepta Therapeutics shares in Q4 2023, an estimated $53.3M.
Artisan Partners first reported a position in Sarepta Therapeutics in Q3 2019 and held it in 9 quarters.
Artisan Partners's Sarepta Therapeutics position peaked at $90.5M in Q4 2020.
395 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2023.

Based on Artisan Partners's 13F filing for Q4 2023, filed 12 Feb 2024.